Two States Sue Cord Blood Bank Over False Advertisements
Cord Blood Registry (CBR), which stores over a million umbilical‑cord samples, is being sued by the attorneys general of Texas and Arizona for allegedly misleading parents about the therapeutic value of its services. The states claim CBR’s advertising falsely promises a "once‑in‑a‑lifetime" chance to treat 80+ conditions, despite limited clinical use of privately banked cord blood. The lawsuits seek removal of deceptive ads and restitution for families who paid thousands of dollars for the service. This legal push follows broader scrutiny of the cord‑blood industry’s marketing practices.
Innovation Proves the Product Works
Dymeka Harrison, a commercialization veteran, argues that breakthrough products alone don’t guarantee lasting companies; adoption hinges on disciplined commercial execution. She cites the 70‑90% startup failure rate as largely driven by underdeveloped commercial foundations. Harrison outlines a holistic commercial system—segmentation,...
Novo Reports More Triple-G Data From China; Grifols Plots IPO for Biopharma Unit
Novo Nordisk announced that its triple‑agonist candidate UBT251 achieved a mean HbA1c reduction of up to 2.16% after 24 weeks in a phase‑2 study of Chinese patients with type‑2 diabetes. The trial, involving roughly 200 participants, underscores the drug’s potential...
Walsh-Turner JV Finishes $1.5B Ohio State University Hospital
Chicago‑based Walsh Construction and New York‑based Turner Construction have completed a new 26‑story, 1.9‑million‑square‑foot hospital for Ohio State University at a construction cost of $1.5 billion. The Wexner Medical Center University Hospital tower houses 820 beds, 24 operating rooms, extensive NICU,...
Alzheimer’s Disease Data Initiative Doubles $1M Prize Competition for Agentic AI Solutions
The Alzheimer’s Disease Data Initiative announced that Biomni-AD and Prima Mente each won the $1 million Alzheimer’s Insights AI Prize, doubling the competition’s total payout to $2 million. The competition, launched in August 2025 and backed by Bill Gates and a broad...
STAT+: Sarepta Therapeutics Shares Rise on Early Promise for Rare Disease Drugs
Sarepta Therapeutics reported that early‑stage trials of two experimental drugs, SRP‑1001 and SRP‑1003, demonstrated safety and signs of efficacy for rare muscle‑wasting disorders. The data sparked a more than 20% surge in the company’s stock during early trading. The results...
Legacy Systems Present Modern Challenges at the VA
Veterans Affairs is phasing out its decades‑old custom electronic health record (EHR) in favor of a modern, interoperable platform, CMIO Dr. Jonathan Nebeker announced. The new system will support standardized data exchange and enable integration of emerging digital tools such...
Xaira’s First Virtual Cell Model Is Largest To-Date, Toward Complex Biology
Xaira Therapeutics unveiled X-Cell, a 4.9‑billion‑parameter virtual cell model that predicts transcriptome‑level responses to genetic perturbations. The model leverages the company’s 25.6 million‑cell X‑Atlas/Pisces CRISPRi Perturb‑seq dataset and demonstrates zero‑shot performance on unseen T‑cell and iPSC contexts. X-Cell uses a diffusion...
New Treatments Target Faulty Genetic Heart Signals
A new DNA‑methylation (episignature) test can differentiate harmful from benign NOTCH1 variants in congenital heart disease, giving families definitive genetic answers. The assay scans over 740,000 genomic sites to identify a characteristic methylation pattern linked to disease‑causing mutations. Positive results...
What Two ER Visits Taught Me About American Healthcare Leadership Failures
The CEO of Sollis Health recounts two COVID‑19 ER visits that revealed how fragmented American healthcare forces patients to coordinate their own care. Despite shared electronic medical records, hospitals rejected each other's data, leading to hours of waiting and unnecessary...
A New Opportunity to Reduce Resident Burnout: Young Doctors Are AI Natives
Resident physicians are experiencing burnout at rates higher than any other U.S. worker, driven by demanding schedules, financial pressures, and limited control over time. Traditional mental‑health services often fail to accommodate their irregular hours, prompting many to turn to AI‑based...
Key Amenity Categories in Luxury Rehabs, According to The Sanctuary at Sedona
The Sanctuary at Sedona outlines a comprehensive luxury rehab checklist that blends high‑end amenities with rigorous clinical care. It highlights seven amenity categories—privacy, clinical depth, personalization, integrative wellness, advanced tech, environment, and hospitality—each designed to improve retention and therapeutic engagement....
Why Gaps in Vaccine Coverage Leave Canadian Employers Exposed
Canadian employers are leaving significant gaps in adult vaccine coverage, with only about 60% of private benefit plans offering any vaccination benefits. Even when coverage exists, reimbursement levels and communication are inconsistent, leading to low uptake among working‑age adults. The...
N.J. EMS Adds Long-Acting Buprenorphine to Prehospital Overdose Care
Cooper EMS in New Jersey has added extended‑release injectable buprenorphine to its prehospital protocols, allowing paramedics to administer a week‑to‑month‑long opioid‑use‑disorder medication after reversing an overdose. The agency previously used sublingual buprenorphine on its Mobile Intensive Care Unit, but the...
Microneedle Vaccine Patch Company Raises $50M for Pivot to GLP-1 Delivery
Terrestrial Bio, the microneedle vaccine patch pioneer originally founded as Vaxess Technologies, announced a $50 million Series B financing round to shift its focus from vaccines to GLP‑1 peptide delivery. The capital, led by a consortium of biotech investors, will fund clinical...
Young People Less Satisfied with the NHS - Survey
The 2025 British Social Attitudes survey shows only one‑in‑five people under 35 are satisfied with the NHS, compared with more than a third of those over 65. Overall satisfaction rose to 26%, the first increase since before the Covid pandemic,...
GrayMatters Health Announces Appointment of Five Expert Advisors
GrayMatters Health announced the appointment of five expert advisors to accelerate the commercial growth of Prism, its digital brain‑biomarker platform for PTSD and depression. The advisors—former Congressman Patrick J. Kennedy and psychiatrists Owen Scott Muir, Linda Carpenter, Kenneth Pages, and...
Study Shows How Lymph Node Architecture Affects Cancer Growth
Researchers from EMBL Heidelberg and partner institutions have created the first detailed map of immune and stromal cell organization within human lymph nodes, revealing how this architecture deteriorates in lymphomas. They discovered an inflammatory vicious cycle where T‑cell interferon signals...
Regeneron and Sanofi Report MHLW’s Approval of Dupixent to Treat Bullous Pemphigoid
Japan’s Ministry of Health, Labour and Welfare approved Dupixent (dupilumab) for adults with moderate-to-severe bullous pemphigoid, marking the first targeted therapy for the disease in the country. The approval is based on the phase II/III ADEPT trial, which enrolled 106...
Why IVF Fails: Top Reasons & How to Improve Your Success
A failed IVF cycle is most often traced to embryonic chromosomal abnormalities, not the transfer itself, with implantation rates dropping from about 43% for women under 35 to roughly 9% for those over 41. The article outlines seven primary failure...
Maze Meets Own Expectations in Phase 2 Kidney Disease Trial in the Same Arena as Vertex
Maze Therapeutics reported that its Phase 2 trial of the genetic kidney disease candidate MZ‑001 achieved its primary efficacy and safety goals, showing a roughly 30% slowdown in eGFR decline versus placebo. The double‑blind study enrolled 150 patients with autosomal dominant...
Ultra-Processed Foods Linked to Behavioral Issues in Pre-Schoolers
A University of Toronto study published in JAMA Network Open found that preschoolers who consume high levels of ultra‑processed foods at age three are more likely to exhibit anxiety, aggression, hyperactivity and fearfulness by age five. The analysis of over...
Hospital Waited Two Days Before Raising Alarm About Meningitis Outbreak
The East Kent Hospitals NHS Trust delayed reporting a suspected meningitis case at Queen Elizabeth the Queen Mother Hospital by two days, breaching the Health Protection Regulations that require immediate notification. The lag slowed contact tracing and public warnings, contributing...
WuXi Biologics Reports Record 2025 Annual Results, Operational Excellence Driven by Digital-Native Architecture
WuXi Biologics reported record 2025 results, with revenue up 16.7% and IFRS gross profit climbing 30.9%, lifting its gross margin to 46%. The growth was driven by expanding research, development and manufacturing contracts and tighter cost control across its global...
Adolescents Are the Missing Middle Falling Through the Cracks of TB Care
Adolescents represent a hidden segment of the tuberculosis epidemic, with roughly 750,000 teens contracting TB worldwide each year and about 20,000 cases in South Africa alone. Because health data split patients into children or adults, teenagers fall between categories, leading...
Children’s Hospital Deadline Will Be Missed Again, Committee Told
The €2.2 billion (≈$2.42 billion) national children’s hospital in Ireland has missed its 18th deadline, with contractor Bam confirming it will not achieve substantial completion by 30 April 2026. The National Paediatric Hospital Development Board (NPHDB) has invoked contract rights, including withholding 15% of...
The Youngest-Ever Female Fortune 500 CEO Is Reinventing the Largest Medicaid Insurer Amid Funding Cuts and Rising Costs
Sarah London has become the youngest-ever female CEO of a Fortune 500 company, taking the helm of Centene, the nation’s largest Medicaid insurer. She is steering the firm through steep federal Medicaid cuts and rising health‑care costs by trimming non‑core...
The United Laboratories and Novo Nordisk Report P-II Trial Data on UBT251 in Chinese Patients with Type 2 Diabetes
Novo Nordisk and United Laboratories reported Phase‑II data for the GLP‑1 agonist UBT251 in 211 Chinese patients with type‑2 diabetes. Over 24 weeks, UBT251 achieved a 2.16 % HbA1c reduction, outperforming semaglutide’s 1.77 % and placebo’s 0.66 % from a baseline of 8.12 %....
Gilead’s Ouro Buy, J&J/Protagonist’s Approval, Aurinia’s Revamp, ACIP Confusion, More
Gilead announced a $2.1 billion acquisition of Ouro Medicines and its T‑cell engager OM336, planning to split the deal with long‑time partner Galapagos. Johnson & Johnson and Protagonist Therapeutics secured FDA approval for Icotyde, an IL‑23 receptor blocker that becomes Protagonist’s...
Genomic Mapping of E. Coli Capsules Identifies High-Risk Types for Vaccines
A genomic survey of over 18,000 *Escherichia coli* genomes has mapped 90 capsular K‑loci, revealing that five capsule types (K1, K5, K52, K2, K14) cause more than half of bloodstream and urinary‑tract infections in Europe. The study links these high‑risk...
World-First Portable Multi-Pathogen CRISPR Test Seeks to Improve STI Diagnostics
Researchers at Australia’s Peter Doherty Institute have created a portable, CRISPR‑based diagnostic that simultaneously detects syphilis, HSV, chlamydia and gonorrhea in under an hour. The assay also identifies a key antibiotic‑resistance gene in gonorrhea, delivering 97‑100% accuracy compared with laboratory...
MSD and Quotient Collaborate on IBD Drug Targets
Merck (MSD) has entered a multi‑year research partnership with Quotient Therapeutics to uncover new drug targets for inflammatory bowel disease using Quotient’s somatic genomics platform. The deal provides Quotient with $20 million upfront and up to $2.2 billion in regulatory, development and...
US-Style Health Care Is Wrong for the UK
A recent BBC and New Statesman investigation uncovered preventable infant deaths at University Hospitals Sussex NHS Foundation Trust, highlighting a deepening maternal‑health crisis in the United Kingdom. Over the past 15 years, maternal mortality rates have risen steadily, exposing gaps in NHS...
Despite Driving Most Disability Claims, MSK Is Solvable
Musculoskeletal (MSK) conditions remain the top driver of disability claims in the U.S., costing employers billions in lost productivity and medical expenses. The article argues that most of this spend is preventable through early, accessible care rather than reactive, high‑cost...
Benefits of Dental Veneers and Why People Choose Them
In 2024 more than 2.3 million Americans chose dental veneers, a 40% surge from five years earlier. Veneers combine cosmetic transformation with a protective seal that can preserve enamel and stave off costly restorative work such as crowns, which typically cost...
Philips Launches IntraSight Plus to Simplify Coronary Interventions and Advance Precision Care
Royal Philips has launched IntraSight Plus, an FDA‑cleared and CE‑marked interventional cardiology platform that unifies intravascular ultrasound, iFR/FFR physiology, and angiographic imaging on a single screen. The system promises up to 47% reduction in procedure time by streamlining data entry...
Milan Longevity Summit 2026: Designing the $120 Trillion “One Health” Future
The Milan Longevity Summit 2026, held May 20‑23 at Allianz MiCo, convenes leaders across finance, AI, agri‑food, urban design and more to re‑engineer systems for an aging world. Using the One Health framework, the event treats human longevity as intertwined...
Pixee Medical’s Knee+ NexSight Receives the European CE Mark for Knee Arthroplasty
Pixee Medical has secured a European CE mark for its Knee+ NexSight augmented‑reality platform, enabling the first EU total knee arthroplasty procedures using the technology. The system projects a voice‑controlled virtual overlay during surgery, delivering robotic‑level precision without a robot,...
Stock to Buy for Long Term: Ventura Sees 39% Upside in This Healthcare Stock. Should You Buy?
Ventura Securities has initiated coverage on Park Medi World Ltd (PMWL) with a Buy rating and a $3.4 target price, suggesting roughly 38% upside over the next two years. The hospital chain, listed at $2.0 per share, leverages a capital‑efficient...
Ionis’ Zilganersen Receives US FDA Priority Review for Alexander Disease
Ionis Pharmaceuticals received FDA acceptance of its new drug application for zilganersen and a priority‑review designation for treating Alexander disease, with a PDUFA target action date of September 22, 2026. The Phase III trial enrolled 54 patients aged 1.5 to 53...
Imaging Manufacturer Guerbet Faces Financial Challenges Following Recent FDA Warning
French imaging contrast agent maker Guerbet is confronting a severe FDA warning after inspectors found significant good manufacturing practice violations at its Raleigh, North Carolina plant. The citation has already depressed Americas revenue by 4% year‑over‑year and reduced MRI‑related sales,...
Indian Man Whose Life Support Was Removed After Court Go-Ahead Dies
Harish Rana, a 31‑year‑old Indian man who had been in a coma since a 2013 balcony fall, died at AIIMS after the Supreme Court authorized the removal of his life‑support machines. The decision marks India’s first court‑approved instance of passive...
Fraudster Faces 3 Years in Prison for Role in $14M Imaging-Related Scheme
A Los Angeles woman, Sophia Shaklian, was sentenced to 35 months in federal prison for orchestrating a Medicare fraud scheme that siphoned more than $14 million through fake diagnostic imaging and hospice services. She owned multiple sham providers and submitted fraudulent...
Unregistered Dentist Offered Treatment to Patients From Sittingroom of Dublin Apartment
The Irish Dental Council disclosed that an unregistered dentist was providing X‑ray treatments from the sitting‑room of a Dublin apartment, exposing a loophole in the Dentists Act 1985 that prevents regulation of non‑licensed practices. The council reported it could not act...
Reforming Public Health in India
The Lancet Commission proposes a citizen‑centred health system for India, outlining six reform actions. It argues that despite adequate per‑capita funding of roughly $24 in many states, the public sector fails to deliver universal health coverage because budgets are fragmented,...
Medicaid’s Newest Reform Is a Morass of Red Tape
Georgia’s "Pathways to Coverage" Medicaid reform, launched in July 2023, aimed to expand coverage for low‑income workers but enrolled only 8,077 of the 240,000 eligible. The program’s private‑contractor‑run IT platform, built by Deloitte for $528 million, generated frequent form changes and...
The Limits Of Efficiency In Home Health’s Cost-Cutting Era
Home‑based care providers are under intense reimbursement pressure, inflation and staffing shortages, prompting a sharp focus on efficiency. Well Care Health, a 700‑employee provider serving 5,000 daily patients across North and South Carolina, warns that cost‑cutting initiatives, especially AI‑driven ones,...
As Antibiotics Fail, a New Treatment Targets the Host, Not the Bacteria
Researchers at Trinity College Dublin have demonstrated that a single dose of interferon‑gamma can “train” human macrophages to more effectively kill drug‑resistant bacteria such as MRSA and Mycobacterium tuberculosis. The IFN‑γ‑trained cells undergo epigenetic reprogramming, rely on glutamine metabolism, and...
This Tiny Implant, Smaller than a Grain of Salt, Can Read Your Brain
Cornell researchers have unveiled the microscale optoelectronic tetherless electrode (MOTE), a neural implant barely larger than a grain of salt. The 300 µm‑by‑70 µm device wirelessly transmits brain‑wave data via infrared light and has demonstrated chronic operation in awake mice for more...
Cancer Drug Can Treat Drug-Resistant Herpes, Too
Researchers at the University of Illinois Chicago have repurposed the FDA‑approved cancer drug doxorubicin to combat drug‑resistant herpes simplex virus type 1 (HSV‑1). Using their AI‑driven platform HerpDock, they identified doxorubicin’s ability to block the PI3K‑AKT‑mTOR pathway that the virus exploits,...